Since calreticulin has been shown in a complex with BIP and Aβ in the cerebrospinal fluids of normal individuals [31], it is conceivable that calreticulin is also involved in preventing aggregation of Aβ in AD brains. Here, CALR is linked to Alzheimer disease.